ASPHALION´S RegTalk | REPOSITORY

July 26, 2022

At ASPHALION, last year we started our “RegTalk” series, one-to-one talks carried out by experts in different areas, aimed at informing about the latest news in the Regulatory Affairs landscape.

📚 📹  We have compiled them all here for you to have them on hand whenever you need them:

 

Topic: Horizon EU-funded projects

“Horizon Europe: Key aspects to prepare a succesful proposal”- Zabala Innovation

https://www.youtube.com/watch?v=gCEJY_K8EcY

 

“Horizon Europe: New challenges”- LEITAT

https://www.youtube.com/watch?v=l0QRVnm8hv8

 

Topic: Clinical Trials Information System (CTIS)

“Key factors about the implementation of the new Clinical Trials Information System (CTIS)”- Asphalion

https://www.youtube.com/watch?v=7plcWvAfBW8

 

Topic: Regulatory Information Management Systems (RIMS)

RegTalk in collaboration with EXTEDO

https://www.youtube.com/watch?v=lOyoAo5xSEo

 

RegTalk in collaboration with ENNOV

https://www.youtube.com/watch?v=zGrHMlZQdlE

 

RegTalk in collaboration with VEEVA

https://www.youtube.com/watch?v=mWm-5pTzPvc

 

RegTalk in collaboration with Körber Pharma Software

https://www.youtube.com/watch?v=QUhAgxqSCU0

 

Topic: eSubmissions

“The secret of Asphalion´s eCTD publishing success”- Asphalion

https://www.youtube.com/watch?v=zajUmBJbTlY

 

We hope the content will be of your interest and you will find it valuable.

Stay tuned for the next RegTalk!! Coming 🔜!!

ℹ For further information, you can contact us at: info@asphalion.com

Search News & Events

  • Filter by category

Share

Related news and events

NEW | MHRA announces new recognition routes

MHRA announces new recognition routes to facilitate safe access to new medicines with seven international partners.
The new recognition routes open additional options for the MHRA to bring cutting-edge medicines faster to UK patients by leveraging the expertise and decision-making of trusted regulatory partners.

PragmaTIL | Kick-off meeting

The launch of the EU-funded PragmaTIL project took place recently in Barcelona. The PragmaTIL trial aims to optimize treatment of cancer patients with Tumour-Infiltrating Lymphocytes

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting